default author photo

Michael Patrick Menden

Helmholtz Zentrum München - Institute of Computational Biology

Germany

  • Helmholtz Zentrum München - Institute of Computational Biology

SCHOLARLY PAPERS

3

DOWNLOADS

170

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany

Number of pages: 22 Posted: 13 Oct 2020
Johanna Erber, Verena Kappler, Bernhard Haller, Hrvoje Mijočević, Ana Galhoz, Clarissa Prazeres da Costa, Friedemann Gebhardt, Natalia Graf, Dieter Hoffmann, Markus Thaler, Elke Lorenz, Hedwig Roggendorf, Florian Kohlmayer, Andreas Henkel, Michael Patrick Menden, Jürgen Ruland, Christoph D. Spinner, Ulrike Protzer, Percy A. Knolle, Paul Lingor and SeCoMRI Study Group
Technische Universität München (TUM) - Department of Internal Medicine II, Technische Universität München (TUM) - Institute of Virology, Technische Universität München (TUM) - Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München (TUM) - Institute of Virology, Helmholtz Zentrum München-German Research - Institute of Computational Biology Centre for Environmental Health -, German Centre for Infection Research (DZIF), Technische Universität München (TUM) - Institute for Medical Microbiology, Technische Universität München (TUM) - Institute of Virology, German Centre for Infection Research (DZIF), Technische Universität München (TUM) - Institute of Clinical Chemistry and Pathobiochemistry, Technische Universität München (TUM) - Department for Sports Medicine, Technische Universität München (TUM) - Institute of Molecular Immunology, Technische Universität München (TUM) - Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München (TUM) - Information Technology Department, Helmholtz Zentrum München - Institute of Computational Biology, University of Tübingen - Institute for Clinical Chemistry and Pathobiochemistry, Technische Universität München (TUM) - Department of Internal Medicine II, Technische Universität München (TUM) - Institute of Virology, German Center of Infection Research (DZIF), Technische Universität München (TUM) - Department of Neurology and Independent
Downloads 97 (704,534)

Abstract:

Loading...

Covid-19, antibody prevalence, cross-sectional study, infection prevention measures, asymptomatic SARS-CoV-2 infection, SARS-CoV-2 transmission, healthcare workers, seroprevalence, hospital staff

2.

Varianz Cohort Reveals Tp53 Mutations as Trastuzumab Response Biomarker in Gastro-Esophageal Cancer

Number of pages: 27 Posted: 12 Jun 2025
Ginte Kutkaite, Ivonne Haffner, Nicole Pfarr, Nikita Makarov, Birgit Luber, Florian Lordick and Michael Patrick Menden
affiliation not provided to SSRN, University of Leipzig, Technische Universität München (TUM) - Institute of Pathology, affiliation not provided to SSRN, Technische Universität München (TUM), University of Leipzig - University Hospital Leipzig and Helmholtz Zentrum München - Institute of Computational Biology
Downloads 41 (1,170,409)

Abstract:

Loading...

precision medicine, Biomarkers, gastric cancer, trastuzumab, HER2, ERBB2, TP53

3.

Identification of Intrinsic Drug Resistance and Their Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens

Number of pages: 34 Posted: 06 Apr 2020
Iñigo Ayestaran, Ben Sidders, Jonathan Dry, Andreas Bender, Ultan McDermott, Francesco Iorio and Michael Patrick Menden
Helmholtz Zentrum München - Institute of Computational Biology, AstraZeneca - Translational Medicine, Research and Early Development, AstraZeneca, University of Cambridge - Centre for Molecular Informatics, AstraZeneca Pharmaceuticals, Wellcome Genome Campus - Wellcome Sanger Institute and Helmholtz Zentrum München - Institute of Computational Biology
Downloads 32 (1,290,922)

Abstract:

Loading...

Precision Medicine, Cancer, Drug Resistance, Early Drug Discovery, Biostatistics, Biomarker Discovery, Drug High-Throughput Screens, Cancer Cell Lines, CRISPR, Drug Combinations